Substance-Related Disorders

"Substance-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders related to substance abuse.

Descriptor ID	D019966
MeSH Number(s)	C25.775 F03.900
Concept/Terms	Substance-Related Disorders Substance-Related Disorders Drug Abuse Drug Abuse Abuse, Drug Drug Dependence Drug Dependence Dependence, Drug Drug Addiction Addiction, Drug Substance Use Disorders Substance Use Disorders Disorder, Substance Use Substance Use Disorder Drug Use Disorders Drug Use Disorders Disorder, Drug Use Drug Use Disorder Organic Mental Disorders, Substance-Induced Organic Mental Disorders, Substance-Induced Organic Mental Disorders, Substance Induced Substance Abuse Substance Abuse Abuse, Substance Abuses, Substance Substance Abuses Substance Dependence Substance Dependence Dependence, Substance Substance Addiction Addiction, Substance Prescription Drug Abuse Prescription Drug Abuse Abuse, Prescription Drug Drug Abuse, Prescription Drug Habituation Drug Habituation Habituation, Drug

Below are MeSH descriptors whose meaning is more general than "Substance-Related Disorders".

Diseases [C]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]

Below are MeSH descriptors whose meaning is more specific than "Substance-Related Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Substance-Related Disorders" by people in this website by year, and whether "Substance-Related Disorders" was a major or minor topic of these publications.

Bar chart showing 577 publications over 31 distinct years, with a maximum of 38 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	3	0	3
1997	4	0	4
1998	2	2	4
1999	3	1	4
2000	1	1	2
2001	5	0	5
2002	9	3	12
2003	17	3	20
2004	14	4	18
2005	11	6	17
2006	18	9	27
2007	19	8	27
2008	22	10	32
2009	15	9	24
2010	11	3	14
2011	15	5	20
2012	27	6	33
2013	18	10	28
2014	19	5	24
2015	22	6	28
2016	16	8	24
2017	33	5	38
2018	20	7	27
2019	24	3	27
2020	31	3	34
2021	21	6	27
2022	13	0	13
2023	20	1	21
2024	13	4	17
2025	2	0	2

Below are the most recent publications written about "Substance-Related Disorders" by people in Profiles.

Jenkins WD, Beach LB, Schneider J, Friedman SR, Pho MT, Walters S, Ezell J, Young AM, Hennessy C, Miller WC, Go VF, Sun C, Seal DW, Westergaard RP, Crane HM, Fredericksen RJ, Ruderman SA, Fletcher S, Ma J, Delaney JA, Plaisance K, Feinberg J, Smith GS, Korthuis PT, Stopka TJ, Friedmann PD, Zule W, Winer M. Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S. J Subst Use Addict Treat. 2025 Apr; 171:209629.

View in: PubMed
Jenkins WD, Pho MT, Nance RM, Young AM, Zule W, Stopka TJ, Friedmann PD, Miller WC, Go VF, Korthuis PT, Westergaard R, Seal DW, Feinberg J, Smith GS, Crane HM, Tsui JI, Lanter T, Choudhary V. Influence of insurance type on healthcare utilization among rural people who use drugs. Drug Alcohol Depend. 2025 Apr 01; 269:112542.

View in: PubMed
Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.

View in: PubMed
Ballard AM, Kesich Z, Crane HM, Feinberg J, Friedmann PD, Go VF, Jenkins WD, Korthuis PT, Miller WC, Pho MT, Seal DW, Smith GS, Stopka TJ, Westergaard RP, Zule WA, Young AM, Cooper HL. Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid Initiative. Drug Alcohol Depend. 2025 Jan 01; 266:112498.

View in: PubMed
Tolan NV, Kang P, Chai PR, Erickson TB, Hayes BD, Uljon SN, Demetriou CA, Melanson SEF. Impact of COVID-19 on Drug Positivity Rates in the Emergency Departments in Boston and Surrounding Areas. J Appl Lab Med. 2024 Nov 04; 9(6):1064-1070.

View in: PubMed
Glynn TR, Khanna SS, Hasdianda MA, O'Cleirigh C, Chai PR. Characterizing syndemic HIV risk profiles and mHealth intervention acceptability among patients in the emergency department. Psychol Health Med. 2025 Jan; 30(1):30-46.

View in: PubMed
Bareis N, Edlund M, Ringeisen H, Guyer H, Dixon LB, Olfson M, Smith TE, Chwastiak L, Monroe-DeVita M, Swartz M, Swanson J, Sinclair Hancq E, Geiger P, Kreski NT, Stroup TS. Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study. Psychiatr Serv. 2025 Jan 01; 76(1):2-12.

View in: PubMed
Robbins R, Weaver MD, Quan SF, Logan RW, Czeisler CA, DiClemente RJ. Exploring sleep difficulties, alcohol, illicit drugs, and suicidal ideation among adolescents with a history of depression. Psychiatry Res. 2024 Oct; 340:116116.

View in: PubMed
Mello MJ, Baird J, Spirito A, Lee LK, Kiragu A, Scott K, Zonfrillo MR, Christison-Lagay E, Bromberg J, Ruest S, Pruitt C, Lawson KA, Nasr IW, Aidlen JT, Maxson RT, Becker S. Implementing Screening, Brief Interventions, and Referral to Treatment at Pediatric Trauma Centers: A Step Wedge Cluster Randomized Trial. J Pediatr Surg. 2024 Nov; 59(11):161618.

View in: PubMed
Chai PR, Goodman GR, Mohamed Y, Bustamante MJ, Albrechta H, Lee JS, Glynn TR, Boland K, Hokayem J, Boyer EW, Rosen RK, Mayer KH, O'Cleirigh C. Leveraging A Digital Pill System to Understand Prevention-Effective Adherence to Oral Hiv Pre-Exposure Prophylaxis Among Men Who Have Sex with Men with Substance Use. AIDS Behav. 2024 Oct; 28(10):3373-3380.

View in: PubMed

People

Explore

Similar Concepts

Top Journals